Slow Bull
The market, slowly. FRIDAY, 25 SEPTEMBER 2026

Catalyst Pharmaceuticals, Inc.

company in Coral Gables, United States

CPRX SEC CIK 1369568
Follow Catalyst Pharmaceuticals Weekly email: filings, results, news

Financials

Reported figures only · latest: Q1 2026 USD · US GAAP
Revenue, last quarter $149.4M +5.6% vs same quarter last year
Net income $63.7M +12.3% vs same quarter last year
EPS, diluted $0.50 +11.1% vs same quarter last year
Operating cash flow $59.6M −0.8% vs same quarter last year
Revenue by quarter
$122.7M
$128.7M
$141.8M
$141.4M
$146.6M
$148.4M
$152.6M
$149.4M
Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$200M$0$200M$400M$600MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$589M$214.3M
FY24$491.7M$163.9M
FY23$398.2M$71.4M
FY22$214.2M$83.1M
FY21$140.8M$39.5M
FY20$119.1M$75M
FY19$102.3M$31.9M
FY18$500K−$34M
FY17$0−$18.4M
FY16$0−$18.1M
FY15$0−$20.2M
FY14$0−$15.5M
FY13$0−$12.2M
FY12$0−$4.1M
FY11-−$6.4M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−8000%−6000%−4000%−2000%0%2000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2585.2%43.8%36.4%
FY2486%39.7%33.3%
FY2386.9%21.8%17.9%
FY2283.9%47.5%38.8%
FY2184.5%37.2%28%
FY2085.7%34.7%63%
FY1985.6%31.1%31.2%
FY18-−7059%−6800.7%
FY17---
FY16---
FY15---
FY14---
FY13---
FY12---
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$100M$0$100M$200M$300MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$208.6M
FY24$239.3M
FY23$143.4M
FY22$116M
FY21$59.4M
FY20$45M
FY19$34.6M
FY18−$26.2M
FY17-
FY16−$18.1M
FY15−$18M
FY14−$13M
FY13−$9.9M
FY12−$5.2M
FY11−$5M
Returned to shareholdersDividends paid and shares bought back
$0$10M$20M$30MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$25.3M
FY24$0
FY23$0
FY22$6.9M
FY21$12.1M
FY20-
FY19-
FY18-
FY17-
FY16-
FY15-
FY14-
FY13-
FY12-
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Catalyst Pharmaceuticals
  • Healthcare median
−8000%−6000%−4000%−2000%0%2000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearCatalyst PharmaceuticalsHealthcare median
FY2536.4%9.8%
FY2433.3%10.5%
FY2317.9%5.3%
FY2238.8%12.7%
FY2128%10.8%
FY2063%-
FY1931.2%-
FY18−6800.7%-
FY17--
FY16--
FY15--
FY14--
FY13--
FY12--
FY11--

News

No stories filed under Catalyst Pharmaceuticals yet - coverage appears here as the news feed clusters it.